Thrive Capital Management (Pennsylvania)’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Buy
+1,106
New +$247K 0.05% 159
2024
Q1
Sell
-4,520
Closed -$354K 171
2023
Q4
$354K Buy
4,520
+430
+11% +$29.3K 0.19% 84
2023
Q3
$257K Buy
4,090
+930
+29% +$61.1K 0.14% 111
2023
Q2
$203K Buy
+3,160
New +$178K 0.12% 134

Other funds holding LRCX

Thrive Capital Management (Pennsylvania)'s LRCX Position: Q1 2026 in Review

Thrive Capital Management (Pennsylvania) opened a new position in Lam Research (LRCX) in Q1 2026: 1,106 shares worth $236K. The stake represents 0.05% of the portfolio and ranks #159 among its holdings. This is a return to the name: Thrive Capital Management (Pennsylvania) previously reported a position in LRCX as recently as Q4 2023.

Thrive Capital Management (Pennsylvania) first reported a position in LRCX in Q2 2023 and has held it in 4 quarters since. The position peaked at $354K in Q4 2023. 2,632 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Thrive Capital Management (Pennsylvania) held 1,106 shares of Lam Research worth $236K as of Q1 2026.
  • Lam Research was a new Thrive Capital Management (Pennsylvania) position in Q1 2026.
  • Lam Research made up 0.05% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #159 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Lam Research in Q2 2023 and has held it in 4 quarters since.
  • Thrive Capital Management (Pennsylvania)'s Lam Research position peaked at $354K in Q4 2023.
  • 2,632 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.